NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Spatial Repellents for Vector Control

CompletedNA

Sponsor: University of Notre Dame

Conditions: Malaria

Interventions: Transfluthrin, Placebo

Countries: Mali

The primary objective of the study is to demonstrate and quantify the protective efficacy of a single Spatial Repellent (SR) product, in reducing malaria infection in a human cohort. The study design will be a prospective cluster Randomized Control Trial (cRCT).

Eligibility overview

Sex: ALL

Age: 6 Months to 10 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Children ≥ 6 months to \< 10 years of age
* Children with Hb \> 7 g/dL and no signs of known chronic disease or other other serious illness
* Sleeps in cluster ≥ 90% of nights during any given month
* Not participating in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial
* Provision of informed consent (and/or assent) form (ICF) signed by the parent(s) or guardian

Exclusion Criteria:

* Children \< 6 months or ≥ 10 years
* Childrend with Hb \<= 7 g/dL with signs of known chronic disease or other serious illness, or Hb \<6 g/dL with signs of clinical decompensation
* Sleeps in cluster \<90% of nights during any given month
* Participating or planned participation in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial
* No provision of ICF (and/or assent) signed by the parent(s) or guardian

Locations (2)

Bamako, Mali
Bamako, Mali